Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.
Financial Results:
Sun Pharma Advanced Research Company Ltd reported Revenues for Q1FY24 of ₹24.00 Crores down from ₹28.00 Crore year on year, a fall of 14.29%.
Total Expenses for Q1FY24 of ₹129.00 Crores up from ₹112.00 Crores year on year, a rise of 15.18%.
Consolidated Net Profit of -₹95.00 Crores from -₹82.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹2.94, from -₹3.03 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.